Answers are grounded in this paper and cite their sources.
Crimean-Congo hemorrhagic fever (CCHF) is a particularly dangerous zoonotic arboviral infection caused by the RNA-containing CCHF virus (CCHFV) of the genus Orthonairovirus in the family Nairoviridae. The disease is characterized by a wide geographic range, covering more than 50 countries in Africa, Asia, and Europe, including regions of Ukraine. The natural circulation of the pathogen is sustained by complex interspecies interactions, in which ixodid ticks of the genus Hyalomma serve as the primary vectors and long-term reservoirs, capable of transphasic and transovarial transmission of the virus. Additional amplifiers of the virus include domestic and wild mammals (cattle, sheep, goats, rodents, and hares), as well as ostriches, in which the infection is typically asymptomatic, while migratory birds contribute to the expansion of the range by transporting infected ticks. Routes of human infection include both vector-borne transmission via tick bites and contact transmission—through exposure to the blood, bodily fluids, or tissues of infected animals during their care or slaughter. In addition, there is a high risk of human-to-human transmission, particularly nosocomial transmission through direct contact with hemorrhagic secretions from patients in the acute phase of the disease. Additional routes of transmission include the alimentary route (through consumption of raw meat or unpasteurized milk) and the sexual route. The pathogenesis and clinical course of CCHF in humans are phasic in nature. Following the incubation period, a prehemorrhagic phase develops, characterized by severe systemic intoxication, which subsequently progresses to the hemorrhagic phase, accompanied by a petechial rash, ecchymoses, multiple internal and external hemorrhages, thrombocytopenia, and a risk of developing disseminated intravascular coagulation and multiple organ failure. The average case-fatality rate is 11.7%. Diagnosis of the disease is based on the use of molecular genetic methods (RT-PCR) during the early days of viremia, as well as serological tests (ELISA) to detect antigens and specific IgM and IgG antibodies. All procedures involving the pathogen require a high level of biosafety (BSL-3/BSL-4). The therapeutic strategy involves intensive pathogenetic and supportive therapy combined with early administration of antiviral drugs, particularly ribavirin. This article provides a detailed description of existing vaccine candidates. Given the lack of commercially available vaccines, specific preventive measures play a key role in preventing outbreaks: acaricidal treatment of animals, use of personal protective equipment, adherence to food hygiene, and strict implementation of infection control measures in healthcare facilities.
No takes yet. Share an insight, caveat, or question.
Задорожна et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: